CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Reyon Pharmaceutical Co Ltd Company Snapshot
Reyon Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Reyon Pharmaceutical Co Ltd with three other companies in this sector in South Korea: Hyundai Pharmaceutical Company Limited (2017 sales of 130.48 billion Korean Won [US$115.61 million] of which 88% was Pharmaceutical), Daehwa Pharmaceutical Company Limited (122.20 billion Korean Won [US$108.27 million] ), and Kukje Pharma Co Ltd (123.31 billion Korean Won [US$109.25 million] of which 92% was Pharmaceutical).

Sales Analysis. During the year ended December of 2017, sales at Reyon Pharmaceutical Co Ltd were 126.25 billion Korean Won (US$111.86 million). This is an increase of 3.6% versus 2016, when the company's sales were 121.85 billion Korean Won. This was the fourth straight year of sales growth at Reyon Pharmaceutical Co Ltd.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Reyon Pharmaceutical Co Ltd
  Stock Performance Chart for Reyon Pharmaceutical Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (8/10/2018): 19,700
(Figures in Korean Won)
1 Week -1.0%   13 Weeks -2.5%  
4 Weeks -23.0%   52 Weeks -4.8%  
 
Reyon Pharmaceutical Co Ltd Key Data:
  Ticker: 102460 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 126,253,125,647
(Year Ending Jan 2018).
Employees: 340
  Currency: Korean Won Market Cap: 330,343,685,500
  Fiscal Yr Ends: December Shares Outstanding: 16,768,715
  Share Type: Common Closely Held Shares: 12,449,007
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.